Press release
Epilepsy Monitoring Devices Market is anticipated to grow up to USD 782 million, at a CAGR of 4.6% during the forecast period 2021-2031
The epilepsy monitoring devices market was valued at USD 499 million in 2021 and it is anticipated to grow up to USD 782 million by 2031, at a CAGR of 4.6% during the forecast period.An abrupt and uncontrollable electrical disruption of the brain is known as epilepsy. It results in modifications to the degree of consciousness, movement, and behavior. Based on different severity levels, there are numerous forms of epilepsy that are common worldwide. Depending on where and how they start in the brain, many types of epilepsy exist. Most epileptic episodes last between 30 seconds and 2 minutes. However, if epilepsy persists for more than five minutes, medical assistance must be summoned. Epilepsy can develop after conditions like meningitis, a stroke, or a closed head injury. Epilepsy's primary etiology is unknown. Computed tomography, implanted advisory systems, electromyography, magnetic resonance imaging (MRI), and EEG machines are some of the most popular epilepsy diagnostic tools. Untreated epilepsy frequently results in loss of coordination, nausea, and vomiting.
Read more about Epilepsy Monitoring Devices Market here: https://www.globalinsightservices.com/reports/epilepsy-monitoring-devices-market/
Market Trends and Drivers:
The increasing incidence and prevalence of epilepsy is boosting the growth of the market during the forecast period. The WHO estimates that five million people are given epilepsy diagnoses each year in the world. According to estimates, epilepsy affects 49 out of every 100,000 people in high-income nations. This number can reach 139 per 100,000 in low- and middle-income nations. This is probably because endemic diseases like malaria and neurocysticercosis are more common, birth traumas and injuries from auto accidents occur more frequently, the medical infrastructure varies, and there are preventive health programs and accessible care options available (in high-income countries).
Market Restraints and Challenges;
Factor such as the high cost of complex epilepsy monitoring procedures and devices is hindering the growth of the market. One of the main factors restricting the global market for epilepsy monitoring devices is the high cost of epilepsy monitoring operations and devices, particularly in developing nations with lax reimbursement systems. Devices for monitoring the brain are quite complicated, and the procedures required to use them are typically pricy.
To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS10282/
COVID-19 Impact:
The COVID-19 outbreak has put medical practises of all sizes under a great deal of stress, and healthcare facilities all across the world are being overrun by the massive number of patients who are coming to see them every day. Other items and services that were not essential to the COVID-19 response operations also showed signs of declining demand and procurement delays. To lower the danger of exposure to doctors, employees, and patients, as well as to conserve resources in order to handle an increase in COVID-19 patients, the majority of hospitals temporarily cancelled elective neurology treatments. Additionally, COVID-19 is increasing supply chain and logistics costs while also fueling uncertainty in important international markets. It's anticipated that this variation in market growth will continue over the upcoming quarters.
Major Players in the Global Epilepsy Monitoring Devices Market:
The key players in the global epilepsy monitoring devices market are Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US), Mitsar Co., Ltd. (Russia), Rimed (US), Emotiv (US), CGX (A Cognionics Company) (US), Mindray Medical International Ltd. (China), Cadwell Industries, Inc. (US), NeuroWave Systems, Inc. (US), and MC10, Inc. (US).
Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS10282/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy Monitoring Devices Market is anticipated to grow up to USD 782 million, at a CAGR of 4.6% during the forecast period 2021-2031 here
News-ID: 2690034 • Views: …
More Releases from Global Insight Services
Submersible Pump Market Is Anticipated To Expand From $14.5 Billion In 2024 To $ …
Market Overview
The Submersible Pump Market is anticipated to expand from $14.5 billion in 2024 to $21.8 billion by 2034, registering a steady CAGR of approximately 4.2%. Submersible pumps are designed for submerged operations in various fluids, enabling efficient water extraction, sewage treatment, and oil and gas applications. These pumps are extensively used across sectors such as agriculture, municipal infrastructure, and industrial processes, offering reliable performance in demanding environments. The market's…
Special Mission Aircraft Market Is Anticipated To Expand From $17.3 Billion In 2 …
Market Overview
The Special Mission Aircraft Market is witnessing substantial expansion, driven by the rising need for versatile and technologically advanced aircraft tailored for unique operational roles. These aircraft are not limited to traditional transport duties but are equipped for specific missions such as intelligence gathering, surveillance, reconnaissance, search and rescue, and maritime patrol. As defense and homeland security agencies worldwide focus on enhancing situational awareness and operational efficiency, the Special…
Medical Tourism Market Is Anticipated To Expand From $115.6 Billion In 2024 To $ …
Market Overview
The Medical Tourism Market has emerged as a transformative force within the global healthcare ecosystem, offering patients an affordable and accessible alternative to high-cost treatments in their home countries. It represents a growing trend where individuals travel abroad to receive medical services ranging from elective cosmetic procedures to complex surgeries. The demand surge is primarily fueled by cost-effectiveness, high-quality care, shorter waiting times, and the availability of advanced treatments…
Magnetic Sensor Market Is Anticipated To Expand From $5.42 Billion In 2024 To $1 …
Market Overview
The Magnetic Sensor Market is anticipated to expand from $5.42 billion in 2024 to $12.48 billion by 2034, growing at a CAGR of approximately 8.7%. This rapid growth reflects the rising integration of magnetic sensing technologies across diverse industries such as automotive, consumer electronics, healthcare, and industrial automation. These sensors are essential for detecting magnetic fields and translating them into electrical signals, enabling applications like navigation, position sensing, current…
More Releases for Epilepsy
Adult mitochondrial epilepsy presentation
Mitochondrial epilepsy is a rare but severe neurological condition caused by genetic mutations that impair mitochondrial function, disrupting cellular energy production in the brain. Patients often present with seizures, developmental delays, and neurodegeneration. It is closely associated with broader mitochondrial diseases such as MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) and Leigh syndrome.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72869
Due to its rarity and complexity, treatment options…
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global…
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Epilepsy Market are:
• Idexx Laboratories Inc.
• PBD Biotech Ltd
• Thermo Fisher Scientific Inc.
• Innovative Diagnostics SAS
• Neogen Corp
• Enfer Labs
• bioMerieux SA
• Ring Biotechnology Co Ltd
• Bionote Inc.
• Shenzhen Bioeasy Biotechnology Co Ltd.
Contact Us:
If you have any queries about this report or if…
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aims…
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 …
The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/A14821
Epilepsy devices play…
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei …
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029
This…
